Table 2.
Number of animals studied with flow cytometry to assess accumulation within cardiac endothelial cells, cardiomyocytes or fibroblasts after the injection of targeted particles within the tail vein.
Endothelial cells (CD31+) |
Cardiomyocytes (MF20+) |
Fibroblasts (Thy1.1+) |
|
---|---|---|---|
No-treatment | 7 | 7 | 4 |
CRPPR, 4 Hrs | 7 | 7 | 5 |
CRPPR, 12 Hrs | 5 | 5 | 3 |